Abbott Laboratories (ABT)

NYSE: ABT · Real-Time Price · USD

131.02

0.27 (0.21%)

At close: May 01, 2025, 11:59 AM

Abbott Laboratories Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	41.95B	40.11B	43.65B	43.08B	34.61B	31.9B	30.58B	27.39B	20.85B
Cost of Revenue	18.71B	17.98B	19.14B	18.54B	15B	13.23B	12.71B	12.34B	9.02B
Gross Profit	23.24B	22.13B	24.51B	24.54B	19.61B	18.67B	17.87B	15.05B	11.83B
Operating Income	6.83B	6.48B	8.36B	8.43B	5.36B	4.53B	3.65B	1.73B	3.19B
Interest Income	344M	385M	183M	43M	46M	94M	105M	124M	99M
Pretax Income	7.01B	6.66B	8.31B	8.21B	4.97B	4.08B	2.87B	2.23B	1.41B
Net Income	13.4B	5.72B	6.93B	7.07B	4.5B	3.69B	2.37B	477M	1.4B
Selling & General & Admin	11.7B	10.95B	11.25B	11.32B	9.7B	9.77B	9.74B	9.12B	6.67B
Research & Development	2.84B	2.74B	2.89B	2.74B	2.42B	2.44B	2.3B	2.23B	1.42B
Other Expenses	1.88B	1.97B	2.01B	2.05B	2.13B	1.94B	139M	1.25B	-945M
Operating Expenses	16.42B	15.66B	16.15B	16.11B	14.25B	14.14B	14.22B	13.33B	8.64B
Interest Expense	559M	637M	375M	490M	500M	576M	721M	780M	332M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	35.13B	33.63B	35.29B	34.65B	29.25B	27.37B	26.93B	25.66B	17.67B
Income Tax Expense	-6.39B	941M	1.37B	1.14B	497M	390M	539M	1.88B	350M
Shares Outstanding (Basic)	1.73B	1.73B	1.75B	1.77B	1.77B	1.77B	1.76B	1.74B	1.47B
Shares Outstanding (Diluted)	1.75B	1.75B	1.76B	1.79B	1.79B	1.78B	1.77B	1.75B	1.48B
EPS (Basic)	7.74	3.30	3.94	3.97	2.52	2.07	1.35	0.27	0.95
EPS (Diluted)	7.64	3.27	3.91	3.94	2.50	2.06	1.34	0.27	0.94
EBITDA	10.83B	10.61B	12.38B	12.74B	8.79B	7.77B	7.12B	6.13B	3.07B
EBIT	7.57B	7.3B	8.86B	8.74B	5.51B	4.75B	3.7B	3.13B	1.84B
Depreciation & Amortization	3.22B	3.24B	3.27B	3.54B	3.33B	3.01B	3.28B	3.02B	1.35B